Gains, Gains, Gains! – Wednesday review, April 29

Gains, Gains, Gains! – Wednesday review, April 29

After a disappointing Consumer Confidence report, the market rejoiced once Gilead announced that it is one step closer to a successful treatment against the novel virus.

The US

Gilead’s statement put Wall Street to work. All benchmarks rallied. USA30 gained 2.09%, while USA500 rose 2.54%. TECH100 added 3.33%.

Oil was up 14.3% to trade at $17.35 per barrel. Brent Oil gained 10.3% to $24.87.

Gold stood still at $1, 710.86 per ounce.

ICE was at 99.584.


Asia and Australia

Good news travels fast across the ocean. The successful trial and the slowing increase in the number of cases impacted the market. Japan225 jumped 2.8%, reaching a seven-week high. Australia's ASX gained 2.7%.

USD/JPY traded higher at 106.56.

AUD/USD was $0.6557.


Europe

In Europe, besides the hype that Gilead created, stocks gained pending the ECB meeting. Europe expects a new stimulus to keep the economy afloat. Europe50 and UK100 gained more than 1% each. Germany30 added 2.89%, while France40 went up 2.22%.

EUR/USD traded higher at $1.0862.


See the difference when trading with CAPEX.com by accessing elite features:

  • Stellar custom service
  • Powerful WebTrader platform and mobile app
  • High-end integrated trading tools
  • Full license and regulation from top regulators


Sources: cnbc.com, investing.com, reuters.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation. Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.


تولت CAPEX.com إعداد المعلومات الواردة هنا دون أن تقصد من ورائها تقديم نصيحة استثمارية. تُقدم المعلومات المذكورة هنا باعتبارها تعليق عام على السوق لأغراض إعلامية فحسب، وبالتالي لم يتم إعدادها وفقاً للمتطلبات القانونية الهادفة لتعزيز استقلالية بحوث الاستثمار، وعليه لا تخضع لأي حظر على التعامل عليها قبل نشر الأبحاث الاستثمارية.

لا يجب على المستخدمين/القراء الاعتماد على المعلومات المقدمة هنا وحدها ويجب على المتلقي إجراء تحليلاته/أبحاثه الخاصة عن طريق قراءة البحث الأساسي الفعلي.تتسم المعلومات الواردة هنا بالعمومية ولا تأخذ في الاعتبار الظروف الشخصية لكل فرد، أو خبراته الاستثمارية أو وضعه المالي الحالي.

وبناء عليه، لن تتحمل Key Way Investments Ltd المسئولية عن أي خسائر يتكبدها المتداولين بسبب استخدام محتوى المعلومات المقدمة هنا. لا يعتبر الأداء السابق مؤشراً موثوقاً على النتائج المستقبلية.